The DOI matches its Crossref record; 151 of the 151 references it cites were found in a registry or an index.
RB1: a prototype tumor suppressor and an enigma
Open accessAbstract
The retinoblastoma susceptibility gene (RB1) was the first tumor suppressor gene to be molecularly defined.RB1 mutations occur in almost all familial and sporadic forms of retinoblastoma, and this gene is mutated at variable frequencies in a variety of other human cancers. Because of its early discovery, the recessive nature of RB1 mutations, and its frequency of inactivation,RB1 is often described as a prototype for the class of tumor suppressor genes. Its gene product (pRB) regulates transcription and is a negative regulator of cell proliferation. Although these general features are well established, a precise description of pRB's mechanism of action has remained elusive. Indeed, in many regards, pRB remains an enigma. This review summarizes some recent developments in pRB research and focuses on progress toward answers for the three fundamental questions that sit at the heart of the pRB literature: What does pRB do? How does the inactivation of RB change the cell? How can our knowledge of RB function be exploited to provide better treatment for cancer patients?
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
2 retracted
Leduc, C., Claverie, P., Eymin, B., Col, E., Khochbin, S., Brambilla, E. M., & Gazzéri, S. (2006) · Oncogene · doi:10.1038/sj.onc.1209446 · Cited by 74
RetractedRETRACTED: The inner centromere–shugoshin network prevents chromosomal instability
Tanno, Y., Susumu, H., Kawamura, M., Sugimura, H., Honda, T., & Watanabe, Y. (2015) · Science · doi:10.1126/science.aaa2655 · Cited by 44
RetractedSherr, C. J. (1996) · Science · doi:10.1126/science.274.5293.1672 · Cited by 5,379 · cited 2×
“The inactivation of pRB compromises the ability of cells to exit the cell cycle, and this places them in a state that is highly susceptible to oncogenic proliferation (for a review, see Hinds and Weinberg 1994; Weinberg 1995; Sherr 1996; Nevins 2001).”
BackgroundThe retinoblastoma protein and cell cycle control
Weinberg, R. A. (1995) · Cell · doi:10.1016/0092-8674(95)90385-2 · Cited by 4,862
The human papilloma virus-16 E7-oncoprotein is able to bind to the retinoblastoma gene product
Dyson, N., Howley, P. M., Münger, K., & Harlow, E. (1989) · Science · doi:10.1126/science.2537532 · Cited by 3,017 · cited 1×
“These tumors develop from progenitor cells that are dependent on Mdm2 (Xu et al. 2009), and, as they also often express high levels of Mdm4 (Laurie et al. 2006), they may be targetable by agents such as Nutlin that activate p53 signaling (Elison et al. 2006; Laurie et al. 2006, 2007).”
BackgroundA human DNA segment with properties of the gene that predisposes to retinoblastoma and osteosarcoma
Friend, S. H., Bernards, R., Rogelj, S., Weinberg, R. A., Rapaport, J. M., Albert, D. M., & Dryja, T. P. (1986) · Nature · doi:10.1038/323643a0 · Cited by 2,948 · cited 2×
“The development of effective inhibitors for Cdk4/6 kinases has been one of the most impactful applications of pRB research (Fry et al. 2004; for review, see Sherr et al. 2016).”
BackgroundMethodSystematic identification of genomic markers of drug sensitivity in cancer cells
Garnett, M. J., Edelman, E. J., Heidorn, S. J., Greenman, C. D., Dastur, A., Lau, K. W., Greninger, P., Thompson, I. R., Luo, X., Soares, J., et al. (2012) · Nature · doi:10.1038/nature11005 · Cited by 2,456
Comprehensive genomic profiles of small cell lung cancer
George, J., Lim, J. S., Jang, S. J., Cun, Y., Ozretić, L., Kong, G., Leenders, F., Lu, X., Fernández-Cuesta, L., Bosco, G., et al. (2015) · Nature · doi:10.1038/nature14664 · Cited by 2,340
Finn, R. S., Crown, J. P., Lang, I., Boer, K., Bondarenko, I. M., Kulyk, S. O., Ettl, J., Patel, R., Pinter, T., Schmidt, M., et al. (2015) · The Lancet Oncology · doi:10.1016/s1470-2045(14)71159-3 · Cited by 1,900 · cited 1×
“…accelerated approval to a combination of the Cdk4/6 inhibitor palbociclib and letrozole for the treatment of hormone receptor-positive advanced breast cancer (Finn et al. 2015), and the efficacy of palbociclib in this setting has been confirmed in subsequent large-scale trials (Turner et al. 2015).”
BackgroundPalbociclib in hormone-receptor-positive advanced breast cancer
Turner, N. C., Ro, J., André, F., Loi, S., Verma, S., Iwata, H., Harbeck, N., Loibl, S., Huang Bartlett, C., Zhang, K., et al. (2015) · New England Journal of Medicine · doi:10.1056/nejmoa1505270 · Cited by 1,590
DeCaprio, J. A., Ludlow, J. W., Figge, J., Shew, J.-Y., Huang, C.-M., Lee, W.-H., Marsilio, E., Paucha, E., & Livingston, D. M. (1988) · Cell · doi:10.1016/0092-8674(88)90559-4 · Cited by 1,459
Human Retinoblastoma Susceptibility Gene: Cloning, Identification, and Sequence
Lee, W.-H., Bookstein, R., Hong, F., Young, L.-J., Shew, J.-Y., & Lee, E. Y.-H. P. (1987) · Science · doi:10.1126/science.3823889 · Cited by 1,417
Whyte, P., Buchkovich, K. J., Horowitz, J. M., Friend, S. H., Raybuck, M., Weinberg, R. A., & Harlow, E. (1988) · Nature · doi:10.1038/334124a0 · Cited by 1,403
Finn, R. S., Dering, J., Conklin, D., Kalous, O., Cohen, D. J., Desai, A. J., Ginther, C., Atefi, M., Chen, I., Fowst, C., et al. (2009) · Breast Cancer Research · doi:10.1186/bcr2419 · Cited by 1,398
Gao, H., Korn, J. M., Ferretti, S., Monahan, J. E., Wang, Y., Singh, M., Zhang, C., Schnell, C., Yang, G., Zhang, Y., et al. (2015) · Nature Medicine · doi:10.1038/nm.3954 · Cited by 1,393
Emerging landscape of oncogenic signatures across human cancers
Ciriello, G., Miller, M. L., Aksoy, B. A., Senbabaoglu, Y., Schultz, N., & Sander, C. (2013) · Nature Genetics · doi:10.1038/ng.2762 · Cited by 1,378
(1993) · Genes & Development · doi:10.1101/gad.7.3.331 · Cited by 1,264
Fry, D. W., Harvey, P. J., Keller, P. R., Elliott, W. L., Meade, M., Trachet, E., Albassam, M., Zheng, X., Leopold, W. R., Pryer, N. K., et al. (2004) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.1427.3.11 · Cited by 1,236 · cited 1×
“Shortly after the cloning of RB1 (Friend et al. 1986; Fung et al. 1987; Lee et al. 1987), it was discovered that a set of viral oncoproteins directly targets pRB and that these physical interactions were necessary for the transforming properties of the viral products (DeCaprio et al. 1988; Whyte et…”
BackgroundThe Rb/E2F pathway: expanding roles and emerging paradigms
Harbour, J. W., & Dean, D. C. (2000) · Genes & Development · doi:10.1101/gad.813200 · Cited by 1,153 · cited 1×
“The fact that RB1 mutant cells fail to arrest at the G1/S transition in response to checkpoint signals (Harrington et al. 1998; Knudsen et al. 1998; Bosco et al. 2007) may explain why RB1 mutant tumors are often sensitive to DNA-damaging agents and why some RB1 mutant tumors initially respond well…”
BackgroundRegulation of retinoblastoma protein functions by ectopic expression of human cyclins
Hinds, P. W., Mittnacht, S., Dulic, V., Arnold, A., Reed, S. I., & Weinberg, R. A. (1992) · Cell · doi:10.1016/0092-8674(92)90249-c · Cited by 995
Cellular mechanisms of tumour suppression by the retinoblastoma gene
Burkhart, D. L., & Sage, J. (2008) · Nature Reviews Cancer · doi:10.1038/nrc2399 · Cited by 974 · cited 1×
“…cohesin loading) (Manning et al. 2014b), addition of nucleosides (which improves replication dynamics and chromosome cohesion) (Bester et al. 2011; Burrell et al. 2013; Manning et al. 2014a), or manipulations that change chromatin marks at centromeric and pericentromeric heterochromatin (Manning…”
BackgroundTargeting CDK4 and CDK6: From Discovery to Therapy
Sherr, C. J., Beach, D., & Shapiro, G. I. (2016) · Cancer Discovery · doi:10.1158/2159-8290.cd-15-0894 · Cited by 936 · cited 1×
“The development of effective inhibitors for Cdk4/6 kinases has been one of the most impactful applications of pRB research (Fry et al. 2004; for review, see Sherr et al. 2016).”
MethodNevins, J. R. (2001) · Human Molecular Genetics · doi:10.1093/hmg/10.7.699 · Cited by 922
Retinoblastoma-protein-dependent cell-cycle inhibition by the tumour suppressor p16
Lukas, J., Parry, D., Aagaard, L., Mann, D. J., Bartkova, J., Strauss, M., Peters, G., & Bartek, J. (1995) · Nature · doi:10.1038/375503a0 · Cited by 899
Replication stress links structural and numerical cancer chromosomal instability
Burrell, R. A., McClelland, S. E., Endesfelder, D., Groth, P., Weller, M.-C., Shaikh, N., Domingo, E., Kanu, N., Dewhurst, S. M., Gronroos, E., et al. (2013) · Nature · doi:10.1038/nature11935 · Cited by 878
Nucleotide deficiency promotes genomic instability in early stages of cancer development
Bester, A. C., Roniger, M., Oren, Y. S., Im, M. M., Sarni, D., Chaoat, M., Bensimon, A., Zamir, G., Shewach, D. S., & Kerem, B. (2011) · Cell · doi:10.1016/j.cell.2011.03.044 · Cited by 858
Structural Evidence for the Authenticity of the Human Retinoblastoma Gene
Fung, Y.-K. T., Murphree, A. L., T'Ang, A., Qian, J., Hinrichs, S. H., & Benedict, W. F. (1987) · Science · doi:10.1126/science.2885916 · Cited by 780
Inactivation of the p53 pathway in retinoblastoma
Laurie, N. A., Donovan, S. L., Shih, C.-S., Zhang, J., Mills, N., Fuller, C., Teunisse, A., Lam, S., Ramos, Y., Mohan, A., et al. (2006) · Nature · doi:10.1038/nature05194 · Cited by 595
Molecular mechanisms underlying RB protein function
Dick, F. A., & Rubin, S. M. (2013) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm3567 · Cited by 569
Hernando, E., Nahlé, Z., Juan, G., Diaz-Rodriguez, E., Alaminos, M., Hemann, M., Michel, L., Mittal, V., Gerald, W., Benezra, R., et al. (2004) · Nature · doi:10.1038/nature02820 · Cited by 562
Tumour-derived p16 alleles encoding proteins defective in cell-cycle inhibition
Koh, J., Enders, G. H., David Dynlacht, B., & Harlow, E. (1995) · Nature · doi:10.1038/375506a0 · Cited by 516
A novel retinoblastoma therapy from genomic and epigenetic analyses
Zhang, J., Benavente, C. A., McEvoy, J., Flores-Otero, J., Ding, L., Chen, X., Ulyanov, A., Wu, G., Wilson, M., Wang, J., et al. (2012) · Nature · doi:10.1038/nature10733 · Cited by 516
Self-citationCyclin D activates the Rb tumor suppressor by mono-phosphorylation
Narasimha, A. M., Kaulich, M., Shapiro, G. S., Choi, Y. J., Sicinski, P., & Dowdy, S. F. (2014) · eLife · doi:10.7554/elife.02872 · Cited by 461
Burrell, R. A., McClelland, S. E., Endesfelder, D., Groth, P., Weller, M.-C., Shaikh, N., Domingo, E., Kanu, N., Dewhurst, S. M., Gronroos, E., et al. (2013) · Nature · doi:10.1038/nature12369 · Cited by 451
CDK 4/6 inhibitors sensitize PIK3CA mutant breast cancer to PI3K inhibitors
Vora, S. R., Juric, D., Kim, N., Mino-Kenudson, M., Huynh, T., Costa, C., Lockerman, E. L., Pollack, S. F., Liu, M., Li, X., et al. (2014) · Cancer Cell · doi:10.1016/j.ccr.2014.05.020 · Cited by 438 · cited 1×
“Cdk4/6 inhibitors synergize strongly with inhibition of HER2, PI3K/mTOR, MEK, IGF1R/IR, and B-RAF (Finn et al. 2009; Franco et al. 2014; Heilmann et al. 2014; Vora et al. 2014; Yadav et al. 2014).”
BackgroundHurford, R. K., Cobrinik, D., Lee, M. H., & Dyson, N. (1997) · Genes & Development · doi:10.1101/gad.11.11.1447 · Cited by 431
Self-citationDickson, M. A., Tap, W. D., Keohan, M. L., D'Angelo, S. P., Gounder, M. M., Antonescu, C. R., Landa, J., Qin, L.-X., Rathbone, D. D., Condy, M. M., et al. (2013) · Journal of Clinical Oncology · doi:10.1200/jco.2012.46.5476 · Cited by 399
Dissecting the Unique Role of the Retinoblastoma Tumor Suppressor during Cellular Senescence
Chicas, A., Wang, X., Zhang, C., McCurrach, M., Zhao, Z., Mert, O., Dickins, R. A., Narita, M., Zhang, M., & Lowe, S. W. (2010) · Cancer Cell · doi:10.1016/j.ccr.2010.01.023 · Cited by 388
BNIP3 Is an RB/E2F Target Gene Required for Hypoxia-Induced Autophagy
Tracy, K., Dibling, B. C., Spike, B. T., Knabb, J. R., Schumacker, P., & Macleod, K. F. (2007) · Molecular and Cellular Biology · doi:10.1128/mcb.02246-06 · Cited by 369
Flaherty, K. T., LoRusso, P. M., DeMichele, A., Abramson, V. G., Courtney, R., Randolph, S. S., Shaik, M. N., Wilner, K. D., O'Dwyer, P. J., & Schwartz, G. K. (2012) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-11-0509 · Cited by 366
Thomas, D. M., Carty, S. A., Piscopo, D. M., Lee, J.-S., Wang, W.-F., Forrester, W. C., & Hinds, P. W. (2001) · Molecular Cell · doi:10.1016/s1097-2765(01)00327-6 · Cited by 361
Retinoblastoma protein partners
(2001) · Advances in Cancer Research · doi:10.1016/s0065-230x(01)82001-7 · Cited by 349
Self-citationDeMichele, A., Clark, A. S., Tan, K. S., Heitjan, D. F., Gramlich, K., Gallagher, M., Lal, P., Feldman, M., Zhang, P., Colameco, C., et al. (2015) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-14-2258 · Cited by 343 · cited 1×
“Cdk4/6 inhibitors hadmodest effects when tested as amonotherapy in solid tumors (Flaherty et al. 2012; Dickson et al. 2013; Cadoo et al. 2014; DeMichele et al. 2015; Vaughn et al. 2015).”
BackgroundThe Requirement for Cyclin D Function in Tumor Maintenance
Choi, Y. J., Li, X., Hydbring, P., Sanda, T., Stefano, J., Christie, A. L., Signoretti, S., Look, A. T., Kung, A. L., von Boehmer, H., et al. (2012) · Cancer Cell · doi:10.1016/j.ccr.2012.09.015 · Cited by 342 · cited 1×
“…have also been implicated in the ineffective erythropoiesis observed in RB1mutantmice (Sankaran et al. 2008), and other studies have shown that autophagy inhibitors also promote a healthy mitochondrial network in RB1 mutant cells and promote differentiation (Ciavarra and Zacksenhaus 2010, 2011).”
A Common Set of Gene Regulatory Networks Links Metabolism and Growth Inhibition
Cam, H., Balciunaite, E., Blais, A., Spektor, A., Scarpulla, R. C., Young, R., Kluger, Y., & Dynlacht, B. D. (2004) · Molecular Cell · doi:10.1016/j.molcel.2004.09.037 · Cited by 322
Rb regulates fate choice and lineage commitment in vivo
Calo, E., Quintero-Estades, J. A., Danielian, P. S., Nedelcu, S., Berman, S. D., & Lees, J. A. (2010) · Nature · doi:10.1038/nature09264 · Cited by 314
Thangavel, C., Dean, J. L., Ertel, A., Knudsen, K. E., Aldaz, C. M., Witkiewicz, A. K., Clarke, R., & Knudsen, E. S. (2011) · Endocrine Related Cancer · doi:10.1530/erc-10-0262 · Cited by 302
Loss of E2F-1 reduces tumorigenesis and extends the lifespan of Rb1(+/−) mice
Yamasaki, L., Bronson, R., Williams, B. O., Dyson, N. J., Harlow, E., & Jacks, T. (1998) · Nature Genetics · doi:10.1038/ng0498-360 · Cited by 283
Self-citationAcetylation control of the retinoblastoma tumour-suppressor protein
Chan, H. M., Krstic-Demonacos, M., Smith, L., Demonacos, C., & Thangue, N. B. L. (2001) · Nature Cell Biology · doi:10.1038/35083062 · Cited by 282
Chen, D., Livne-bar, I., Vanderluit, J. L., Slack, R. S., Agochiya, M., & Bremner, R. (2004) · Cancer Cell · doi:10.1016/j.ccr.2004.05.025 · Cited by 281
Mad2-induced chromosome instability leads to lung tumour relapse after oncogene withdrawal
Sotillo, R., Schvartzman, J.-M., Socci, N. D., & Benezra, R. (2010) · Nature · doi:10.1038/nature08803 · Cited by 273
E2F transcription factor-1 regulates oxidative metabolism
Blanchet, E., Annicotte, J.-S., Lagarrigue, S., Aguilar, V., Clapé, C., Chavey, C., Fritz, V., Casas, F., Apparailly, F., Auwerx, J., et al. (2011) · Nature Cell Biology · doi:10.1038/ncb2309 · Cited by 271
Xu, X. L., Fang, Y., Lee, T. C., Forrest, D., Gregory-Evans, C., Almeida, D., Liu, A., Jhanwar, S. C., Abramson, D. H., & Cobrinik, D. (2009) · Cell · doi:10.1016/j.cell.2009.03.051 · Cited by 246
Deciphering the retinoblastoma protein phosphorylation code
Rubin, S. M. (2013) · Trends in Biochemical Sciences · doi:10.1016/j.tibs.2012.10.007 · Cited by 245
pRB plays an essential role in cell cycle arrest induced by DNA damage
Harrington, E. A., Bruce, J. L., Harlow, E., & Dyson, N. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.20.11945 · Cited by 242
Self-citationLoss of pRB causes centromere dysfunction and chromosomal instability
Manning, A. L., Longworth, M. S., & Dyson, N. J. (2010) · Genes & Development · doi:10.1101/gad.1917310 · Cited by 240
Self-citationRb suppresses human cone-precursor-derived retinoblastoma tumours
Xu, X. L., Singh, H. P., Wang, L., Qi, D.-L., Poulos, B. K., Abramson, D. H., Jhanwar, S. C., & Cobrinik, D. (2014) · Nature · doi:10.1038/nature13813 · Cited by 235
Methylation of the Retinoblastoma Tumor Suppressor by SMYD2
Saddic, L. A., West, L. E., Aslanian, A., Yates, J. R., Rubin, S. M., Gozani, O., & Sage, J. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.m110.137612 · Cited by 223
Control of glutamine metabolism by the tumor suppressor Rb
Reynolds, M. R., Lane, A. N., Robertson, B., Kemp, S., Liu, Y., Hill, B. G., Dean, D. C., & Clem, B. F. (2014) · Oncogene · doi:10.1038/onc.2012.635 · Cited by 216 · cited 2×
“These alterations include reduced mitochondrial respiration, reduced activity in the electron transport chain, changes inmitochondrial polarity, and altered flux from glucose or glutamine in RB1 mutant cells (Sankaran et al. 2008; Clem and Chesney 2012; Nicolay et al. 2013, 2015; Reynolds et al. 2014; for review, see…”
BackgroundInhibition of DNA synthesis by RB: effects on G1/S transition and S-phase progression
Knudsen, E. S., Buckmaster, C., Chen, T.-T., Feramisco, J. R., & Wang, J. Y. J. (1998) · Genes & Development · doi:10.1101/gad.12.15.2278 · Cited by 210
Franco, J., Witkiewicz, A. K., & Knudsen, E. S. (2014) · Oncotarget · doi:10.18632/oncotarget.2270 · Cited by 207
Hinds, P. W., & Weinberg, R. A. (1994) · Current Opinion in Genetics & Development · doi:10.1016/0959-437x(94)90102-3 · Cited by 207
Kareta, M. S., Gorges, L. L., Hafeez, S., Benayoun, B. A., Marro, S., Zmoos, A.-F., Cecchini, M. J., Spacek, D., Batista, L. F. Z., O’Brien, M., et al. (2015) · Cell Stem Cell · doi:10.1016/j.stem.2014.10.019 · Cited by 198
The retinoblastoma tumor suppressor modifies the therapeutic response of breast cancer
Bosco, E. E., Wang, Y., Xu, H., Zilfou, J. T., Knudsen, K. E., Aronow, B. J., Lowe, S. W., & Knudsen, E. S. (2007) · Journal of Clinical Investigation · doi:10.1172/jci28803 · Cited by 192
Therapeutic Targeting of the Cyclin D3:CDK4/6 Complex in T Cell Leukemia
Sawai, C. M., Freund, J., Oh, P., Ndiaye-Lobry, D., Bretz, J. C., Strikoudis, A., Genesca, L., Trimarchi, T., Kelliher, M. A., Clark, M., et al. (2012) · Cancer Cell · doi:10.1016/j.ccr.2012.09.016 · Cited by 183
Schvartzman, J.-M., Duijf, P. H. G., Sotillo, R., Coker, C., & Benezra, R. (2011) · Cancer Cell · doi:10.1016/j.ccr.2011.04.017 · Cited by 181
Dick, F. A., & Dyson, N. J. (2003) · Molecular Cell · doi:10.1016/s1097-2765(03)00344-7 · Cited by 179
Self-citationBinné, U. K., Classon, M. K., Dick, F. A., Wei, W., Rape, M., Kaelin, W. G., Näär, A. M., & Dyson, N. J. (2007) · Nature Cell Biology · doi:10.1038/ncb1532 · Cited by 175
Self-citationErtel, A., Dean, J. L., Rui, H., Liu, C., Witkiewicz, A., Knudsen, K. E., & Knudsen, E. S. (2010) · Cell Cycle · doi:10.4161/cc.9.20.13454 · Cited by 173
Burke, J. R., Deshong, A. J., Pelton, J. G., & Rubin, S. M. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.m110.108167 · Cited by 171
The search for the retinoblastoma cell of origin
Dyer, M. A., & Bremner, R. (2005) · Nature Reviews Cancer · doi:10.1038/nrc1545 · Cited by 170 · cited 1×
“…(Friend et al. 1986; Fung et al. 1987; Lee et al. 1987), it was discovered that a set of viral oncoproteins directly targets pRB and that these physical interactions were necessary for the transforming properties of the viral products (DeCaprio et al. 1988; Whyte et al. 1988; Dyson et al. 1989).”
BackgroundJi, P., Jiang, H., Rekhtman, K., Bloom, J., Ichetovkin, M., Pagano, M., & Zhu, L. (2004) · Molecular Cell · doi:10.1016/j.molcel.2004.09.029 · Cited by 170
The search for the retinoblastoma cell of origin
Dyer, M. A., & Bremmer, R. (2005) · American Journal of Ophthalmology · doi:10.1016/j.ajo.2005.05.013 · Cited by 168
The retinoblastoma tumor-suppressor gene, the exception that proves the rule
Goodrich, D. W. (2006) · Oncogene · doi:10.1038/sj.onc.1209616 · Cited by 164
Lin, W., Cao, J., Liu, J., Beshiri, M. L., Fujiwara, Y., Francis, J., Cherniack, A. D., Geisen, C., Blair, L. P., Zou, M. R., et al. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1110104108 · Cited by 163
Structures of inactive retinoblastoma protein reveal multiple mechanisms for cell cycle control
Burke, J. R., Hura, G. L., & Rubin, S. M. (2012) · Genes & Development · doi:10.1101/gad.189837.112 · Cited by 155
Wells, J. M., Yan, P. S., Cechvala, M. M., Huang, T. H. ‐., & Farnham, P. (2003) · Oncogene · doi:10.1038/sj.onc.1206264 · Cited by 150
CENPA overexpression promotes genome instability in pRb-depleted human cells
Amato, A. M., Schillaci, T., Lentini, L., & Leonardo, A. D. (2009) · Molecular Cancer · doi:10.1186/1476-4598-8-119 · Cited by 147
The retinoblastoma protein induces apoptosis directly at the mitochondria
Hilgendorf, K. I., Leshchiner, E. S., Nedelcu, S., Maynard, M. A., Calo, E., Ianari, A., Walensky, L. D., & Lees, J. A. (2013) · Genes & Development · doi:10.1101/gad.211326.112 · Cited by 146
Mitotic chromosome condensation mediated by the retinoblastoma protein is tumor-suppressive
Coschi, C. H., Martens, A. L., Ritchie, K., Francis, S. M., Chakrabarti, S., Bérubé, N. G., & Dick, F. A. (2010) · Genes & Development · doi:10.1101/gad.1917610 · Cited by 143
Proapoptotic Function of the Retinoblastoma Tumor Suppressor Protein
Ianari, A., Natale, T., Calo, E., Ferretti, E., Alesse, E., Screpanti, I., Haigis, K. M., Gulino, A., & Lees, J. A. (2009) · Cancer Cell · doi:10.1016/j.ccr.2009.01.026 · Cited by 142
The retinoblastoma gene family is differentially expressed during embryogenesis
Jiang, Z., Zacksenhaus, E., Gallie, B. L., & Phillips, R. A. (1997) · Oncogene · doi:10.1038/sj.onc.1201014 · Cited by 136
Rb intrinsically promotes erythropoiesis by coupling cell cycle exit with mitochondrial biogenesis
Sankaran, V. G., Orkin, & Walkley, C. R. (2008) · Genes & Development · doi:10.1101/gad.1627208 · Cited by 133 · cited 4×
“…reduced activity in the electron transport chain, changes inmitochondrial polarity, and altered flux from glucose or glutamine in RB1 mutant cells (Sankaran et al. 2008; Clem and Chesney 2012; Nicolay et al. 2013, 2015; Reynolds et al. 2014; for review, see Nicolay and Dyson 2013; Lopez-Mejia and…”
BackgroundInfluentialWang, H., Bauzon, F., Ji, P., Xu, X. L., Sun, D., Locker, J. D., Sellers, R. S., Nakayama, K., Nakayama, K. I., Cobrinik, D. E., et al. (2009) · Nature Genetics · doi:10.1038/ng.498 · Cited by 133
Loss of Rb proteins causes genomic instability in the absence of mitogenic signalingPreprint
van Harn, T., Foijer, F., van Vugt, M. A. T. M., Banerjee, R., Yang, F., Oostra, A. B., Joenje, H., & Riele, H. T. (2010) · Genes & Development · doi:10.1101/gad.580710 · Cited by 132
Yadav, V., Burke, T. F., Huber, L., Van Horn, R. D., Zhang, Y., Buchanan, S. G., Chan, E. M., Starling, J. J., Beckmann, R. P., & Peng, S.-B. (2014) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-14-0257 · Cited by 132
The retinoblastoma tumor suppressor and stem cell biology
Sage, J. (2012) · Genes & Development · doi:10.1101/gad.193730.112 · Cited by 130
Ferrari, R., Gou, D., Jawdekar, G. W., Johnson, S., Nava, M., Su, T., Yousef, A. F., Zemke, N. R., Pellegrini, M. A., Kurdistani, S. K., et al. (2014) · Cell Host & Microbe · doi:10.1016/j.chom.2014.10.004 · Cited by 130
A Novel Rb- and p300-Binding Protein Inhibits Transactivation by MyoD
MacLellan, W. R., Xiao, G., Abdellatif, M., & Schneider, M. D. (2000) · Molecular and Cellular Biology · doi:10.1128/mcb.20.23.8903-8915.2000 · Cited by 125 · cited 2×
“Changes that activate differentiation programs are one potential strategy (MacLellan et al. 2000; Lasorella et al. 2005; Lin et al. 2011).”
BackgroundLysine methylation regulates the pRb tumour suppressor protein
Munro, S., Khaire, N., Inche, A. G., Carr, S. M., & Thangue, N. B. L. (2010) · Oncogene · doi:10.1038/onc.2009.511 · Cited by 124
Acetylation regulates the differentiation‐specific functions of the retinoblastoma protein
Nguyen, D. X., Baglia, L. A., Huang, S.-M. A., Baker, C. M., & McCance, D. J. (2004) · The EMBO Journal · doi:10.1038/sj.emboj.7600176 · Cited by 122
Longworth, M. S., Herr, A., Ji, J.-Y., & Dyson, N. J. (2008) · Genes & Development · doi:10.1101/gad.1631508 · Cited by 122
Self-citationHeilmann, A. M., Perera, R. M., Ecker, V., Nicolay, B. N., Bardeesy, N., Benes, C. H., & Dyson, N. J. (2014) · Cancer Research · doi:10.1158/0008-5472.can-13-2923 · Cited by 119 · cited 4×
“The mitotic phenotypes resulting from pRB loss have been linked to the altered expression of mitotic proteins (Hernando et al. 2004), reduced loading of the Condensin II protein CapD3 (Longworth et al. 2008; Coschi et al. 2010; Manning et al. 2010), reduced chromosomal cohesion (Manning et al.…”
BackgroundInfluentialSelf-citationInhibition of Rb Phosphorylation Leads to mTORC2-Mediated Activation of Akt
Zhang, J., Xu, K. L., Liu, P., Geng, Y., Wang, B., Gan, W., Guo, J., Wu, F., Chin, Y. R., Berrios, C. J., et al. (2016) · Molecular Cell · doi:10.1016/j.molcel.2016.04.023 · Cited by 116
Carr, S. M., Munro, S., Kessler, B. M., Oppermann, U. C. T., & Thangue, N. B. L. (2010) · The EMBO Journal · doi:10.1038/emboj.2010.311 · Cited by 115
Aagaard, L., Lukas, J., Bártková, J., Kjerulff, A. A., Strauss, M., & Bártek, J. (1995) · International Journal of Cancer · doi:10.1002/ijc.2910610120 · Cited by 115
Palbociclib: an evidence-based review of its potential in the treatment of breast cancer
Traina, T. A., Cadoo, K. A., & Gucalp, A. (2014) · Breast Cancer Targets and Therapy · doi:10.2147/bctt.s46725 · Cited by 113
A Small-Molecule E2F Inhibitor Blocks Growth in a Melanoma Culture Model
Ma, Y., Kurtyka, C. A., Boyapalle, S., Sung, S., Lawrence, H. R., Guida, W. C., & Cress, W. D. (2008) · Cancer Research · doi:10.1158/0008-5472.can-08-0121 · Cited by 113
Miyake, S., Sellers, W. R., Safran, M., Li, X., Zhao, W., Grossman, S. R., Gan, J., DeCaprio, J. A., Adams, P. D., & Kaelin, W. G. (2000) · Molecular and Cellular Biology · doi:10.1128/mcb.20.23.8889-8902.2000 · Cited by 112
Id2 Mediates Tumor Initiation, Proliferation, and Angiogenesis in Rb Mutant Mice
Lasorella, A., Rothschild, G., Yokota, Y., Russell, R. G., & Iavarone, A. (2005) · Molecular and Cellular Biology · doi:10.1128/mcb.25.9.3563-3574.2005 · Cited by 111
Regulation of the PDK4 Isozyme by the Rb-E2F1 Complex
Hsieh, M., Das, D., Sambandam, N., Zhang, M. Q., & Nahle, Z. A. (2008) · Journal of Biological Chemistry · doi:10.1074/jbc.m802418200 · Cited by 111
Diversity within the pRb pathway: is there a code of conduct?
Munro, S., Carr, S. M., & Thangue, N. B. L. (2012) · Oncogene · doi:10.1038/onc.2011.603 · Cited by 105
Retinoblastoma Tumor Suppressor Targets dNTP Metabolism to Regulate DNA Replication
Angus, S. P., Wheeler, L. J., Ranmal, S. A., Zhang, X., Markey, M. P., Mathews, C. K., & Knudsen, E. S. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m205911200 · Cited by 104
Regulation of transcription and chromatin structure by pRB: Here, there and everywhere
Talluri, S., & Dick, F. A. (2012) · Cell Cycle · doi:10.4161/cc.21263 · Cited by 100
Loss of RBF1 changes glutamine catabolism
Nicolay, B., Gameiro, P. A., Tschöp, K., Korenjak, M., Heilmann, A. M. F., Asara, J. M., Stephanopoulos, G. N., Iliopoulos, O., & Dyson, N. J. (2013) · Genes & Development · doi:10.1101/gad.206227.112 · Cited by 100
Self-citationRole of the Retinoblastoma Protein in Differentiation and Senescence
Thomas, D. M., Yang, H.-S., Alexander, K., & Hinds, P. W. (2003) · Cancer Biology & Therapy · doi:10.4161/cbt.2.2.235 · Cited by 100 · cited 1×
“…of RB1 can alter the type of differentiation programs that are activated, the extent of differentiation that occurs, and the ability of differentiated cells to permanently exit the cell cycle (for examples, see Thomas et al. 2001; Calo et al. 2010; for review, see Thomas et al. 2003; Sage 2012).”
BackgroundCell cycle regulation of mitochondrial function
López‐Mejía, I. C., & Fajas, L. (2014) · Current Opinion in Cell Biology · doi:10.1016/j.ceb.2014.10.006 · Cited by 99
The multiple connections between pRB and cell metabolism
Nicolay, B., & Dyson, N. J. (2013) · Current Opinion in Cell Biology · doi:10.1016/j.ceb.2013.07.012 · Cited by 95
Self-citationRB acute loss induces centrosome amplification and aneuploidy in murine primary fibroblasts
Iovino, F., Lentini, L., Amato, A., & Di Leonardo, A. (2006) · Molecular Cancer · doi:10.1186/1476-4598-5-38 · Cited by 94
Ziebold, U., Lee, E. Y., Bronson, R. T., & Lees, J. A. (2003) · Molecular and Cellular Biology · doi:10.1128/mcb.23.18.6542-6552.2003 · Cited by 94
Newly identified aspects of tumor suppression by RB
Viatour, P., & Sage, J. (2011) · Disease Models & Mechanisms · doi:10.1242/dmm.008060 · Cited by 94
Haploinsufficiency of an RB–E2F1–Condensin II Complex Leads to Aberrant Replication and Aneuploidy
Coschi, C. H., Ishak, C. A., Gallo, D., Marshall, A. E., Talluri, S., Wang, J., Cecchini, M. J., Martens, A. L., Percy, V., Welch, I. D., et al. (2014) · Cancer Discovery · doi:10.1158/2159-8290.cd-14-0215 · Cited by 92
Váraljai, R., Islam, A. B. M. M. K., Beshiri, M. L., Rehman, J., López-Bigas, N., & Benevolenskaya, E. V. (2015) · Genes & Development · doi:10.1101/gad.264036.115 · Cited by 88
Suppression of Genome Instability in pRB-Deficient Cells by Enhancement of Chromosome Cohesion
Manning, A. L., Yazinski, S. A., Nicolay, B., Bryll, A. R., Zou, L., & Dyson, N. J. (2014) · Molecular Cell · doi:10.1016/j.molcel.2014.01.032 · Cited by 88
Self-citationSharma, A. M., Comstock, C. E. S., Knudsen, E. S., Cao, K. H., Hess-Wilson, J. K., Morey, L. M., Barrera, J. G., & Knudsen, K. E. (2007) · Cancer Research · doi:10.1158/0008-5472.can-06-4424 · Cited by 87
Nicolay, B., Danielian, P. S., Kottakis, F., Lapek, J. D., Sanidas, I., Miles, W. O., Dehnad, M., Tschöp, K., Gierut, J. J., Manning, A. L., et al. (2015) · Genes & Development · doi:10.1101/gad.264127.115 · Cited by 85
Self-citationSmall Molecule Inhibition of HDM2 Leads to p53-Mediated Cell Death in Retinoblastoma Cells
Elison, J. R., Cobrinik, D., Claros, N., Abramson, D. H., & Lee, T. C. (2006) · Archives of Ophthalmology · doi:10.1001/archopht.124.9.1269 · Cited by 84
Markey, M. P., Bergseid, J., Bosco, E. E., Stengel, K. R., Xu, H., Mayhew, C. N., Schwemberger, S. J., Braden, W. A., Jiang, Y., Babcock, G. F., et al. (2007) · Oncogene · doi:10.1038/sj.onc.1210450 · Cited by 82
Developmental defects and tumor predisposition in Rb mutant mice
Vooijs, M., & Berns, A. J. M. (1999) · Oncogene · doi:10.1038/sj.onc.1202999 · Cited by 82
Distinct gene expression phenotypes of cells lacking Rb and Rb family members.
Black, E. P., Huang, E. S., Dressman, H. K., Rempel, R. E., Laakso, N., Asa, S. L., Ishida, S., West, M., & Nevins, J. R. (2003) · PubMed · Cited by 81
Zhao, H., Bauzon, F., Fu, H., Lu, Z., Cui, J., Nakayama, K., Nakayama, K. I., Locker, J. D., & Zhu, L. (2013) · Cancer Cell · doi:10.1016/j.ccr.2013.09.021 · Cited by 80
MacDonald, J. I., & Dick, F. A. (2012) · Genes & Cancer · doi:10.1177/1947601912473305 · Cited by 80
Dick, F. A. (2007) · Cell Division · doi:10.1186/1747-1028-2-26 · Cited by 79
Redeployment of Myc and E2f1–3 drives Rb-deficient cell cycles
Liu, H., Tang, X., Srivastava, A., Pécot, T., Daniel, P., Hemmelgarn, B. T., Reyes, S., Fackler, N., Bajwa, A., Kladney, R. D., et al. (2015) · Nature Cell Biology · doi:10.1038/ncb3210 · Cited by 75
Vaughn, D. J., Hwang, W., Lal, P., Rosen, M. A., Gallagher, M., & O'Dwyer, P. J. (2015) · Cancer · doi:10.1002/cncr.29213 · Cited by 74
Witkiewicz, A. K., Ertel, A., McFalls, J. M., Valsecchi, M. E., Schwartz, G. F., & Knudsen, E. S. (2012) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-12-0903 · Cited by 74
Sangwan, M. L., McCurdy, S. R., Livne‐Bar, I., Ahmad, M. A. E.-R., Wrana, J. L., Chen, D., & Bremner, R. (2012) · Oncogene · doi:10.1038/onc.2011.654 · Cited by 73
Macleod, K. F. (2008) · Nature reviews. Cancer · doi:10.1038/nrc2504 · Cited by 73
Deficiency of Retinoblastoma gene in mouse embryonic stem cells leads to genetic instability.
Zheng, L., Flesken‐Nikitin, A., Chen, P., & Lee, W. (2002) · PubMed · Cited by 72
Specific Killing of Rb Mutant Cancer Cells by Inactivating TSC2
Li, B., Gordon, G. M., Du, C. H., Xu, J., & Du, W. (2010) · Cancer Cell · doi:10.1016/j.ccr.2010.03.019 · Cited by 69
A systems biology dynamical model of mammalian G1 cell cycle progression
Haberichter, T., Mädge, B., Christopher, R. A., Yoshioka, N., Dhiman, A., Miller, R. E., Gendelman, R., Aksenov, S., Khalil, I. G., & Dowdy, S. F. (2007) · Molecular Systems Biology · doi:10.1038/msb4100126 · Cited by 62
Emerging Links between E2F Control and Mitochondrial Function
Benevolenskaya, E. V., & Frolov, M. V. (2015) · Cancer Research · doi:10.1158/0008-5472.can-14-2173 · Cited by 57
Lysine methylation-dependent binding of 53BP1 to the pRb tumor suppressor
Carr, S. M., Munro, S., Zalmas, L., Fedorov, O., Johansson, C., Krojer, T. J., Sagum, C. A., Bedford, M. T., Oppermann, U. C. T., & Thangue, N. B. L. (2014) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1403737111 · Cited by 55
Skp2 suppresses apoptosis in Rb1-deficient tumours by limiting E2F1 activity
Lu, Z., Bauzon, F., Fu, H., Cui, J., Zhao, H., Nakayama, K., Nakayama, K. I., & Zhu, L. (2014) · Nature Communications · doi:10.1038/ncomms4463 · Cited by 55
Whole chromosome instability resulting from the synergistic effects of pRB and p53 inactivation
Manning, A. L., Benes, C. H., & Dyson, N. J. (2013) · Oncogene · doi:10.1038/onc.2013.201 · Cited by 54
Self-citationCiavarra, G., & Zacksenhaus, E. (2010) · The Journal of Cell Biology · doi:10.1083/jcb.201005067 · Cited by 53
E2F function in muscle growth is necessary and sufficient for viability in Drosophila
Zappia, M. P., & Frolov, M. V. (2016) · Nature Communications · doi:10.1038/ncomms10509 · Cited by 52
E2F Inhibition Synergizes with Paclitaxel in Lung Cancer Cell Lines
Kurtyka, C. A., Chen, L., & Cress, W. D. (2014) · PLoS ONE · doi:10.1371/journal.pone.0096357 · Cited by 48
Revisiting lncRNAs: How Do You Know Yours Is Not an eRNA?
Espinosa, J. M. (2016) · Molecular Cell · doi:10.1016/j.molcel.2016.03.022 · Cited by 48
Targeting MDM2 and MDMX in Retinoblastoma
Laurie, N. A., Schin-Shih, C., & Dyer, M. A. (2007) · Current Cancer Drug Targets · doi:10.2174/156800907782418266 · Cited by 46
E2f binding-deficient Rb1 protein suppresses prostate tumor progression in vivo
Sun, H., Wang, Y., Chinnam, M., Zhang, X., Hayward, S. W., Foster, B. A., Nikitin, A. Y., Wills, M. L., & Goodrich, D. W. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1015027108 · Cited by 44
Molecular Pathways: Regulation of Metabolism by RB
Clem, B. F., & Chesney, J. A. (2012) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-11-3164 · Cited by 41
Parisi, T., Yuan, T. L., Faust, A. M. E., Caron, A. M., Bronson, R. T., & Lees, J. A. (2007) · Molecular and Cellular Biology · doi:10.1128/mcb.01854-06 · Cited by 40
Kim, K. Y., Wang, D.-H., Campbell, M., Huerta, S. B., Shevchenko, B., Izumiya, C., & Izumiya, Y. (2014) · Molecular and Cellular Biology · doi:10.1128/mcb.00945-14 · Cited by 40
Evidence for a mitochondrial localization of the retinoblastoma protein
Ferecatu, I., Floch, N. L., Bergeaud, M., Rodriguez-Enfedaque, A., Rincheval, V., Oliver, L., Vallette, F. M., Mignotte, B., & Vayssière, J. (2009) · BMC Cell Biology · doi:10.1186/1471-2121-10-50 · Cited by 35
Loss of dE2F compromises mitochondrial function
Ambrus, A. M., Islam, A. B. M. M. K., Holmes, K. B., Moon, N. S., Lopez-Bigas, N., Benevolenskaya, E. V., & Frolov, M. V. (2013) · Developmental Cell · doi:10.1016/j.devcel.2013.10.002 · Cited by 34 · cited 2×
“While the mechanistic basis for these metabolic changes has not been fully elucidated, these results are consistent with reports showing that E2F and RB proteins bind directly to promoters of genes encoding important regulators of metabolic flux, oxidative phosphorylation, and mitochondrial function (Cam et al. 2004;…”
BackgroundPritchard, E. M., Stewart, E. A., Zhu, F., Bradley, C. L., Griffiths, L. M., Yang, L., Suryadevara, P. K., Zhang, J., Freeman, B. B., Guy, R. K., et al. (2014) · Pharmaceutical Research · doi:10.1007/s11095-014-1399-y · Cited by 28
Attardi, L. D., & Sage, J. (2013) · Genes & Development · doi:10.1101/gad.219451.113 · Cited by 23
Multiple pathways counteract cell death induced by RB1 loss: Implications for cancer
Ciavarra, G., & Zacksenhaus, E. (2011) · Cell Cycle · doi:10.4161/cc.10.10.15520 · Cited by 21
Gordon, G. M., Zhang, T., Zhao, J., & Du, W. (2013) · Journal of Cell Science · doi:10.1242/jcs.121301 · Cited by 18
Zhao, H., Bauzon, F., Bi, E., Yu, J., Fu, H., Lu, Z., Cui, J., Jeon, H., Zang, X., Ye, B. H., et al. (2015) · Journal of Biological Chemistry · doi:10.1074/jbc.m114.625350 · Cited by 12
Cited by
Mechanisms of Cellular Senescence: Cell Cycle Arrest and Senescence Associated Secretory Phenotype
Kumari, R., & Jat, P. (2021) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2021.645593 · Cited by 1,622
Cell cycle regulation: p53-p21-RB signaling
Engeland, K. (2022) · Cell Death & Differentiation · doi:10.1038/s41418-022-00988-z · Cited by 1,274
The broken cycle: E2F dysfunction in cancer
Kent, L. N., & Leone, G. (2019) · Nature Reviews Cancer · doi:10.1038/s41568-019-0143-7 · Cited by 800
Tumor biomarkers for diagnosis, prognosis and targeted therapy
Zhou, Y., Tao, L., Qiu, J., Xu, J., Yang, X., Zhang, Y., Tian, X., Guan, X., Cen, X., & Zhao, Y. (2024) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-024-01823-2 · Cited by 720
Glioma targeted therapy: insight into future of molecular approaches
Yang, K., Wu, Z., Zhang, H., Zhang, N., Wu, W., Wang, Z., Dai, Z., Zhang, X., Zhang, L., Peng, Y., et al. (2022) · Molecular Cancer · doi:10.1186/s12943-022-01513-z · Cited by 704
Metadata
- Authors
- Dyson, N. J.
- Venue
- Genes & Development
- Publisher
- Cold Spring Harbor Laboratory
- Published
- 2016-07-01
- Volume
- 30
- Issue
- 13
- Pages
- 1492-1502
- ISSN
- 0890-9369 (ISSN-L)
- 1549-5477
- OpenAlex
- W2471978271
- Cited by
- 435
- References
- 151
- Type
- posted content
- Language
- en
- Open access
- diamond
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.